Innovation, makers of PharmASSIST® pharmacy automation solutions, today announced that the U.S. Navy has awarded the company a 5-Yearm Indefinite Delivery/Indefinite Quantity contract up to $49 million to supply pharmacy automation technologies to U.S. Navy high-volume sites and outpatient pharmacies around the world. According to the U.S. Navy, Innovation was the only company who fully met the technical requirements of their published Generic Functional Systems Requirement (GFSR). ?Innovation is pleased that the U.S. Navy has awarded us this significant contract to upgrade their pharmacies? prescription fulfillment processes and quality control,? said Mary Reno, CEO, Innovation. ?We look forward to this opportunity to assist Navy pharmacies in achieving their goal of standardized workflow and dispensing platforms. Most importantly, our various technologies will help Navy pharmacies reach the specific quality objectives that they require to ensure the utmost in patient safety for our service men and women.?

The main objectives of this U.S. Navy initiative are to:
• Replace current ?end-of-life? pharmacy automation equipment and provide a more standardized process flow for many of the naval outpatient pharmacies
• Improve the quality of dispensing by reducing the opportunities for errors
• Increase the volume capability while reducing the wait time for patients
• Reduce operating costs related to improved inventory management, efficient staff utilization, and increased security

U.S. Navy hospitals previously acquired their pharmacy automation systems individually. The new contract calls for central acquisition and management to enable U.S. Navy outpatient pharmacies to implement a standardized pharmacy automation system throughout the life of the contract.